Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Luigi Di Puorto
Institution:
University of Campania "Luigi Vanvitelli"
Observed institution:
University of Campania "Luigi Vanvitelli"
ORCID:
0009-0007-9705-0037
Observed ORCID:
0009-0007-9705-0037
OpenAlex ID:
A5120591395
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives
2025
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Journal of Personalized Medicine
·
3
PDF
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives
2026
·
Mario Romeo
, Claudio Basile
, et al.
·
Cells
·
2
PDF
THU-186-YI Distinct cardiometabolic profiles drive divergent HCC risk trajectories in advanced fibrosis-affected MASLD patients
2026
·
Mario Romeo
, Marcello Dallio
, et al.
·
Journal of Hepatology
·
1
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes
2026
·
Mario Romeo
, Claudio Basile
, et al.
·
Cancers
·
1
PDF
Comparative Performance of MAFLD and MASLD Criteria for Predicting de novo Hepatocellular Carcinoma in HCV-Infected Patients After Sustained Virological Response
2026
·
Claudio Basile
, Mario Romeo
, et al.
·
Digestive and Liver Disease
PDF
Chronic exposure to microplastic-associated Bisphenol A drives progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by promoting immunometabolic and epigenetic reprogramming of Trained Immunity
2026
·
Marcello Dallio
, Mario Romeo
, et al.
·
Digestive and Liver Disease
PDF
From FIB-4 to the Artificial Intelligence Era: The Evolution of Non-Invasive Tools (NITs) for Tailored Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2026
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Livers
Acnmd26-39: Comparative Evaluation of Mafld Versus Masld Diagnostic Criteria for Predicting De Novo Hepatocellular Carcinoma (hcc) Risk in Hcv-infected Individuals Following Sustained Virological Response
2026
·
Fiammetta Di Nardo
, Marcello Dallio
, et al.
·
Digestive and Liver Disease
Show more works
View as search
Works count:
8
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type